Literature DB >> 25972063

Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.

Hideo Yanai1, Noboru Yahara2, Takumi Furuya2, Hiroto Hayashi2, Tomoyuki Murakami3, Yuzo Shimokawa4, Shigenori Sugihara5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 25972063     DOI： 10.1007/s12029-015-9729-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  17 in total

1.  Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations.

Authors:  H Watanabe; M Enjoji; T Imai
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

2.  Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.

Authors:  Wen-hai Feng; Bruce Israel; Nancy Raab-Traub; Pierre Busson; Shannon C Kenney
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

3.  Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.

Authors:  Hye-Jong Song; Amitabh Srivastava; Jeeyun Lee; Yun Soo Kim; Kyoung-Mee Kim; Won Ki Kang; Minji Kim; Seonwoo Kim; Cheol Keun Park; Sung Kim
Journal:  Gastroenterology       Date:  2010-04-14       Impact factor: 22.682

4.  Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction.

Authors:  A P Burke; T S Yen; K M Shekitka; L H Sobin
Journal:  Mod Pathol       Date:  1990-05       Impact factor: 7.842

5.  Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.

Authors:  Jung Seon Seo; Tai-Gyu Kim; Young Seon Hong; Jen-Yang Chen; Suk Kyeong Lee
Journal:  Arch Pharm Res       Date:  2011-05-05       Impact factor: 4.946

6.  Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma.

Authors:  H Yanai; J Nishikawa; Y Mizugaki; N Shimizu; K Takada; K Matsusaki; T Toda; Y Matsumoto; M Tada; K Okita
Journal:  Gastrointest Endosc       Date:  1997-03       Impact factor: 9.427

7.  Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.

Authors:  M Constanza Camargo; Woo-Ho Kim; Anna Maria Chiaravalli; Kyoung-Mee Kim; Alejandro H Corvalan; Keitaro Matsuo; Jun Yu; Joseph J Y Sung; Roberto Herrera-Goepfert; Fernando Meneses-Gonzalez; Yuko Kijima; Shoji Natsugoe; Linda M Liao; Jolanta Lissowska; Sung Kim; Nan Hu; Carlos A Gonzalez; Yashushi Yatabe; Chihaya Koriyama; Stephen M Hewitt; Suminori Akiba; Margaret L Gulley; Philip R Taylor; Charles S Rabkin
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

8.  Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan.

Authors:  H Matsunou; F Konishi; H Hori; T Ikeda; K Sasaki; Y Hirose; N Yamamichi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

9.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

10.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321
View more
  1 in total

1.  Endoscopic and pathologic motifs for the clinical diagnosis of Epstein-Barr virus-associated gastric cancer.

Authors:  Hideo Yanai; Daisuke Chihara; Megumi Harano; Eiki Sakaguchi; Tomoyuki Murakami; Jun Nishikawa
Journal:  DEN open       Date:  2021-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.